Frankfurt - Delayed Quote EUR

Algorae Pharmaceuticals Limited (LHI0.F)

Compare
0.0030 0.0000 (0.00%)
As of 8:12:51 AM GMT+1. Market Open.
Loading Chart for LHI0.F
DELL
  • Previous Close 0.0030
  • Open 0.0030
  • Bid 0.0030 x --
  • Ask 0.0045 x --
  • Day's Range 0.0030 - 0.0030
  • 52 Week Range 0.0005 - 0.0100
  • Volume 293,000
  • Avg. Volume 5,203
  • Market Cap (intraday) 7.162M
  • Beta (5Y Monthly) 0.72
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Feb 26, 2025 - Mar 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company's product pipeline includes AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient for the of treatment for dementia, including Alzheimer's disease; NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient to treat cardiovascular disease, including hypertension. It is also developing AlgaraeOS in partnership with the University of New South Wales, an artificial intelligence platform for biopharmaceutical prediction of both fixed dose combination drug targets and repurposed drug targets agnostic to medical indication. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. Algorae Pharmaceuticals Limited was founded in 1987 and is based in Melbourne, Australia.

algoraepharma.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: LHI0.F

View More

Performance Overview: LHI0.F

Trailing total returns as of 12/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

LHI0.F
100.00%
S&P/ASX 200 [XJO]
7.61%

1-Year Return

LHI0.F
20.00%
S&P/ASX 200 [XJO]
9.07%

3-Year Return

LHI0.F
57.14%
S&P/ASX 200 [XJO]
11.83%

5-Year Return

LHI0.F
57.14%
S&P/ASX 200 [XJO]
19.54%

Compare To: LHI0.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LHI0.F

View More

Valuation Measures

Annual
As of 12/18/2024
  • Market Cap

    8.15M

  • Enterprise Value

    6.28M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    2.78

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -26.67%

  • Return on Equity (ttm)

    -61.85%

  • Revenue (ttm)

    125.2k

  • Net Income Avi to Common (ttm)

    -2.1M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.11M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -482.58k

Research Analysis: LHI0.F

View More

Company Insights: LHI0.F

Research Reports: LHI0.F

View More